Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Establishment of the black-tailed prairie dog (Cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered preexposure in both high- and low-dose monkeypox virus challenges.

Keckler MS, Carroll DS, Gallardo-Romero NF, Lash RR, Salzer JS, Weiss SL, Patel N, Clemmons CJ, Smith SK, Hutson CL, Karem KL, Damon IK.

J Virol. 2011 Aug;85(15):7683-98. doi: 10.1128/JVI.02174-10. Epub 2011 Jun 1.

2.

Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations.

Townsend MB, Keckler MS, Patel N, Davies DH, Felgner P, Damon IK, Karem KL.

J Virol. 2013 Jan;87(2):900-11. doi: 10.1128/JVI.02089-12. Epub 2012 Nov 7.

3.

Monkeypox disease transmission in an experimental setting: prairie dog animal model.

Hutson CL, Carroll DS, Gallardo-Romero N, Weiss S, Clemmons C, Hughes CM, Salzer JS, Olson VA, Abel J, Karem KL, Damon IK.

PLoS One. 2011;6(12):e28295. doi: 10.1371/journal.pone.0028295. Epub 2011 Dec 2.

4.

Transmissibility of the monkeypox virus clades via respiratory transmission: investigation using the prairie dog-monkeypox virus challenge system.

Hutson CL, Gallardo-Romero N, Carroll DS, Clemmons C, Salzer JS, Nagy T, Hughes CM, Olson VA, Karem KL, Damon IK.

PLoS One. 2013;8(2):e55488. doi: 10.1371/journal.pone.0055488. Epub 2013 Feb 7. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/18ebd26a-21ef-43ff-b20d-c22f433e5714.

5.

Orthopoxvirus variola infection of Cynomys ludovicianus (North American black tailed prairie dog).

Carroll DS, Olson VA, Smith SK, Braden ZH, Patel N, Abel J, Li Y, Damon IK, Karem KL.

Virology. 2013 Sep 1;443(2):358-62. doi: 10.1016/j.virol.2013.05.029. Epub 2013 Jun 27.

6.

A prairie dog animal model of systemic orthopoxvirus disease using West African and Congo Basin strains of monkeypox virus.

Hutson CL, Olson VA, Carroll DS, Abel JA, Hughes CM, Braden ZH, Weiss S, Self J, Osorio JE, Hudson PN, Dillon M, Karem KL, Damon IK, Regnery RL.

J Gen Virol. 2009 Feb;90(Pt 2):323-33. doi: 10.1099/vir.0.005108-0.

PMID:
19141441
7.

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.

Earl PL, Americo JL, Wyatt LS, Eller LA, Whitbeck JC, Cohen GH, Eisenberg RJ, Hartmann CJ, Jackson DL, Kulesh DA, Martinez MJ, Miller DM, Mucker EM, Shamblin JD, Zwiers SH, Huggins JW, Jahrling PB, Moss B.

Nature. 2004 Mar 11;428(6979):182-5.

PMID:
15014500
8.

Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.

Stittelaar KJ, Neyts J, Naesens L, van Amerongen G, van Lavieren RF, Holý A, De Clercq E, Niesters HG, Fries E, Maas C, Mulder PG, van der Zeijst BA, Osterhaus AD.

Nature. 2006 Feb 9;439(7077):745-8. Epub 2005 Dec 11.

PMID:
16341204
9.

Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.

Earl PL, Americo JL, Wyatt LS, Espenshade O, Bassler J, Gong K, Lin S, Peters E, Rhodes L Jr, Spano YE, Silvera PM, Moss B.

Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10889-94. doi: 10.1073/pnas.0804985105. Epub 2008 Aug 4.

10.

Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus.

Smith SK, Self J, Weiss S, Carroll D, Braden Z, Regnery RL, Davidson W, Jordan R, Hruby DE, Damon IK.

J Virol. 2011 Sep;85(17):9176-87. doi: 10.1128/JVI.02173-10. Epub 2011 Jun 22.

11.

Evaluation of monkeypox virus infection of black-tailed prairie dogs (Cynomys ludovicianus) using in vivo bioluminescent imaging.

Falendysz EA, Londoño-Navas AM, Meteyer CU, Pussini N, Lopera JG, Osorio JE, Rocke TE.

J Wildl Dis. 2014 Jul;50(3):524-36. doi: 10.7589/2013-07-171. Epub 2014 Apr 29.

12.

Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model.

Garza NL, Hatkin JM, Livingston V, Nichols DK, Chaplin PJ, Volkmann A, Fisher D, Nalca A.

Vaccine. 2009 Sep 4;27(40):5496-504. doi: 10.1016/j.vaccine.2009.06.105. Epub 2009 Jul 24.

13.

Dosage comparison of Congo Basin and West African strains of monkeypox virus using a prairie dog animal model of systemic orthopoxvirus disease.

Hutson CL, Carroll DS, Self J, Weiss S, Hughes CM, Braden Z, Olson VA, Smith SK, Karem KL, Regnery RL, Damon IK.

Virology. 2010 Jun 20;402(1):72-82. doi: 10.1016/j.virol.2010.03.012. Epub 2010 Apr 5.

14.

Comparison of Monkeypox Virus Clade Kinetics and Pathology within the Prairie Dog Animal Model Using a Serial Sacrifice Study Design.

Hutson CL, Carroll DS, Gallardo-Romero N, Drew C, Zaki SR, Nagy T, Hughes C, Olson VA, Sanders J, Patel N, Smith SK, Keckler MS, Karem K, Damon IK.

Biomed Res Int. 2015;2015:965710. doi: 10.1155/2015/965710. Epub 2015 Aug 24.

15.

A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.

Stabenow J, Buller RM, Schriewer J, West C, Sagartz JE, Parker S.

J Virol. 2010 Apr;84(8):3909-20. doi: 10.1128/JVI.02012-09. Epub 2010 Feb 3.

16.

A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.

Buchman GW, Cohen ME, Xiao Y, Richardson-Harman N, Silvera P, DeTolla LJ, Davis HL, Eisenberg RJ, Cohen GH, Isaacs SN.

Vaccine. 2010 Sep 14;28(40):6627-36. doi: 10.1016/j.vaccine.2010.07.030. Epub 2010 Jul 24.

17.

Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.

Stittelaar KJ, van Amerongen G, Kondova I, Kuiken T, van Lavieren RF, Pistoor FH, Niesters HG, van Doornum G, van der Zeijst BA, Mateo L, Chaplin PJ, Osterhaus AD.

J Virol. 2005 Jun;79(12):7845-51.

18.

Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.

Kennedy JS, Gurwith M, Dekker CL, Frey SE, Edwards KM, Kenner J, Lock M, Empig C, Morikawa S, Saijo M, Yokote H, Karem K, Damon I, Perlroth M, Greenberg RN.

J Infect Dis. 2011 Nov;204(9):1395-402. doi: 10.1093/infdis/jir527. Epub 2011 Sep 15.

19.

Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques.

Denzler KL, Babas T, Rippeon A, Huynh T, Fukushima N, Rhodes L, Silvera PM, Jacobs BL.

Vaccine. 2011 Dec 6;29(52):9684-90. doi: 10.1016/j.vaccine.2011.09.135. Epub 2011 Oct 12.

PMID:
22001879
20.

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.

Hooper JW, Thompson E, Wilhelmsen C, Zimmerman M, Ichou MA, Steffen SE, Schmaljohn CS, Schmaljohn AL, Jahrling PB.

J Virol. 2004 May;78(9):4433-43.

Items per page

Supplemental Content

Write to the Help Desk